| New molecular insights into osteosarcoma targeted therapy J Yang, W Zhang Current opinion in oncology 25 (4), 398-406, 2013 | 313 | 2013 |
| Histone deacetylase 6 in cancer T Li, C Zhang, S Hassan, X Liu, F Song, K Chen, W Zhang, J Yang Journal of hematology & oncology 11, 1-10, 2018 | 308 | 2018 |
| Advances in targeted therapy for osteosarcoma W Zhou, M Hao, X Du, K Chen, G Wang, J Yang Discovery medicine 17 (96), 301-307, 2014 | 176 | 2014 |
| Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma J Yang, D Yang, Y Sun, B Sun, G Wang, JC Trent, DM Araujo, K Chen, ... Cancer 117 (21), 4925-4938, 2011 | 139 | 2011 |
| Genetic aberrations in soft tissue leiomyosarcoma J Yang, X Du, K Chen, A Ylipää, AJF Lazar, J Trent, D Lev, R Pollock, ... Cancer letters 275 (1), 1-8, 2009 | 123 | 2009 |
| Genetic aberrations of gastrointestinal stromal tumors J Yang, X Du, AJF Lazar, R Pollock, K Hunt, K Chen, X Hao, J Trent, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 120 | 2008 |
| Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug J Yang, JA Eddy, Y Pan, A Hategan, I Tabus, Y Wang, D Cogdell, ... Molecular & cellular proteomics 9 (11), 2405-2413, 2010 | 82 | 2010 |
| Roles of low-density lipoprotein receptor-related protein 1 in tumors P Xing, Z Liao, Z Ren, J Zhao, F Song, G Wang, K Chen, J Yang Chinese journal of cancer 35, 1-8, 2016 | 80 | 2016 |
| Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment J Yang, A Ylipää, Y Sun, H Zheng, K Chen, M Nykter, J Trent, N Ratner, ... Clinical cancer research 17 (24), 7563-7573, 2011 | 78 | 2011 |
| Mesenchymal to epithelial transition in sarcomas J Yang, X Du, G Wang, Y Sun, K Chen, X Zhu, AJF Lazar, KK Hunt, ... European journal of cancer 50 (3), 593-601, 2014 | 77 | 2014 |
| Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma J Yang, D Cogdell, D Yang, L Hu, H Li, H Zheng, X Du, Y Pang, J Trent, ... Cancer letters 291 (1), 31-38, 2010 | 73 | 2010 |
| Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China F Li, Z Liao, J Zhao, G Zhao, X Li, X Du, Y Yang, J Yang Oncotarget 8 (38), 64471, 2017 | 68 | 2017 |
| A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma C Zhang, H Shen, T Yang, T Li, X Liu, J Wang, Z Liao, J Wei, J Lu, H Liu, ... Nature communications 13 (1), 7250, 2022 | 67 | 2022 |
| The genetic basis for inactivation of Wnt pathway in human osteosarcoma X Du, J Yang, D Yang, W Tian, Z Zhu BMC cancer 14, 1-10, 2014 | 67 | 2014 |
| IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma T Li, C Zhang, G Zhao, X Zhang, M Hao, S Hassan, M Zhang, H Zheng, ... Cancer letters 477, 19-30, 2020 | 66 | 2020 |
| Advances in targeted therapy for unresectable melanoma: new drugs and combinations M Hao, F Song, X Du, G Wang, Y Yang, K Chen, J Yang Cancer letters 359 (1), 1-8, 2015 | 61 | 2015 |
| The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute J Yang, Z Ren, X Du, M Hao, W Zhou Stem cell investigation 1, 18, 2014 | 61 | 2014 |
| APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma: Correlation with Recurrence, Metastasis, and Survival J Yang, D Yang, D Cogdell, X Du, H Li, Y Pang, Y Sun, L Hu, B Sun, ... Technology in cancer research & treatment 9 (2), 161-169, 2010 | 59 | 2010 |
| Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients WY Zhou, H Zheng, XL Du, JL Yang Cancer biology & medicine 13 (2), 260-268, 2016 | 56 | 2016 |
| Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors A Ylipää, KK Hunt, J Yang, AJF Lazar, KE Torres, DC Lev, M Nykter, ... Cancer 117 (2), 380-389, 2011 | 52 | 2011 |
Wei Zhang PhD, Professor of Cancer...The Comprehensive Cancer Center of Wake Forest Baptist Medical Centerبريد إلكتروني تم التحقق منه على wakehealth.edu
